You have accessJournal of UrologyBladder Cancer: Staging1 Apr 2015PD41-02 A NEW PROPOSAL FOR T1, HIGH GRADE (HG) BLADDER CANCER (BCA) MICRO-STAGING DEFINITION Rodolfo Fausto Hurle, Carlo Patriarca, Luisa Pasini, Pier Giuseppe Colombo, Giario Natale Conti, Massimo Freschi, Fabio Capogrosso, Marco Moschini, Lucia Ferrari, Massimo Maffezzini, Maurizio Colecchia, Tiziana Magnani, Andrea Conti, and Renzo Colombo Rodolfo Fausto HurleRodolfo Fausto Hurle More articles by this author , Carlo PatriarcaCarlo Patriarca More articles by this author , Luisa PasiniLuisa Pasini More articles by this author , Pier Giuseppe ColomboPier Giuseppe Colombo More articles by this author , Giario Natale ContiGiario Natale Conti More articles by this author , Massimo FreschiMassimo Freschi More articles by this author , Fabio CapogrossoFabio Capogrosso More articles by this author , Marco MoschiniMarco Moschini More articles by this author , Lucia FerrariLucia Ferrari More articles by this author , Massimo MaffezziniMassimo Maffezzini More articles by this author , Maurizio ColecchiaMaurizio Colecchia More articles by this author , Tiziana MagnaniTiziana Magnani More articles by this author , Andrea ContiAndrea Conti More articles by this author , and Renzo ColomboRenzo Colombo More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2015.02.2410AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Histological T1 sub-staging has been advocated as a potential prognostic factor. However, the absence of a standardized method, the inter-observers variability and the absence of a clear clinical validation prevent the spreading of T1 sub-staging in routine practice. This study was aimed to assess both feasibility and prognostic reliability of a new procedure (ROL) for the assessment of the T1 sub-staging in comparison to the other well known sub-staging methods METHODS The ROL sub-staging was defined as ROL 1: < 1 PF (20x) corresponding to 1mm of lamina propria thickness invasion and as ROL 2: > 1 PF (20x) or multifocality sizing more than 1mm of lamina propria invasion. Multiple slides of a series of consecutive patients with T1HG (2004-WHO classification) BCa at initial TUR were revised by uro-pathologists of four different centers. Both feasibility and prognostic reliability of ROL method were compared to those of T1a/T1b,c subdivision (above or under the muscolaris mucosae) and T1m/T1e subdivision (< 1 HPF 40x vs > 1 HPF 40x or multifocality), according to Angulo and to van Rhijn methods, respectively. Progression free survival (PFS) and recurrence-free survival (RFS) were analyzed by KM estimation. Univariable Cox regression analyses were used to test the risk factors associated with a detrimental effect on survival RESULTS Out of a total of 318 patients, 250 patients who received a second-TURB were confirmed as T1HG and entered the study. Mean age was 71 years and 40 patients were female. At a mean follow up of 45 months, 116 patients (36.5%) have a recurrence, 36 (11.3%) have a progression and 52 underwent radical cystectomy. The ROL methods was feasible in 99.7% of cases compared to 72.3% for Angulo and 99.7% for van Rhijn, respectively. RFS was 74% and 26% for T1a and T1b/c, 41% and 59 for T1m and T1e and 53.4% and 46.6% for ROL 1 and ROL 2 method, respectively (all p>0.2). PFS survival at 3 year follow-up was 94% and 76% for T1a and T1b,c (p=0.04), 91% and 92% for T1m and T1e (p=0.2), and 95% and 90% for ROL 1 and ROL 2 (p=0.04), respectively CONCLUSIONS According to the results of this retrospective study, the new threshold of sub-staging (ROL 1/2) of pT1HG was documented to be feasible in all cases, easy to report and reproducible due to its objective standardized definition. In addition, the ROL sub-staging resulted as a reliable predictor of oncologic outcomes also when compared to other sub-staging systems. These results may have a great impact in clinical practice and deserve to be confirmed in prospective multicentric investigations © 2015 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 193Issue 4SApril 2015Page: e840 Advertisement Copyright & Permissions© 2015 by American Urological Association Education and Research, Inc.MetricsAuthor Information Rodolfo Fausto Hurle More articles by this author Carlo Patriarca More articles by this author Luisa Pasini More articles by this author Pier Giuseppe Colombo More articles by this author Giario Natale Conti More articles by this author Massimo Freschi More articles by this author Fabio Capogrosso More articles by this author Marco Moschini More articles by this author Lucia Ferrari More articles by this author Massimo Maffezzini More articles by this author Maurizio Colecchia More articles by this author Tiziana Magnani More articles by this author Andrea Conti More articles by this author Renzo Colombo More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...
Read full abstract